Differences in Biomarker Testing in Non-Small Cell Lung Cancer (NSCLC): Real-World Experience Within an Integrated Healthcare System

被引：0
|
作者：
Alcasid, Nathan
Sarovar, Varada
Yang, Jingrong
Sakoda, Lori
Velotta, Jeffrey
机构：
[1] Univ Calif San Francisco, Oakland, CA USA
[2] Kaiser Permanente Northern Calif, Div Res, Oakland, CA USA
[3] Kaiser Permanente Northern Calif, Div Thorac Surg, Oakland, CA USA
来源：
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS | 2024年 / 239卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
引用
收藏
页码：S484 / S484
页数：1
相关论文
共 50 条
  • [1] REAL-WORLD UTILIZATION PATTERNS AND OUTCOMES OF BIOMARKER TESTING FOR NON-SMALL CELL LUNG CANCER IN AN INTEGRATED HEALTHCARE SYSTEM
    Alcasid, Nathan
    Tupper, Haley I.
    Sarovar, Varada
    Dong, Huyun
    Dyer, Wendy
    Yang, Jingrong
    Patel, Ashish
    Ashiku, Simon K.
    Sakoda, Lori
    Velotta, Jeffrey B.
    CHEST, 2024, 166 (04) : 4368A - 4369A
  • [2] Real-world biomarker testing trends in metastatic non-small cell lung cancer (NSCLC).
    Clinton, Natasha
    Patel, Manish R.
    Ayars, Michael
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18728 - E18728
  • [3] Real-World Experience of Consolidation Durvalumab for Locally Advanced Non-Small Cell Lung Cancer (NSCLC)
    Barbaro, A.
    Mienko, F.
    Deng, L.
    Ohri, N.
    Halmos, B.
    Perez-Soler, R.
    Gucalp, R.
    Bodner, W.
    Cheng, H.
    JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S906 - S907
  • [4] Real-world experience of treatment with afatinib in advanced non-small cell lung cancer (NSCLC) in Vietnam
    Dong, H.
    Tuan, K. Nguyen
    Bui, T. T. P.
    Dong, H.
    ANNALS OF ONCOLOGY, 2022, 33 : S1590 - S1590
  • [5] REAL-WORLD PATTERNS OF BIOMARKER TESTING IN METASTATIC NON-SQUAMOUS NON-SMALL CELL LUNG CANCER
    Roncadori, A.
    Massa, I
    Balzi, W.
    Danesi, V
    Rengucci, C.
    Gentili, N.
    Crino, L.
    Delmonte, A.
    Altini, M.
    VALUE IN HEALTH, 2022, 25 (01) : S255 - S255
  • [6] REAL-WORLD UTILIZATION OF BRIGATINIB IN PATIENTS WITH NON-SMALL CELL LUNG CANCER (NSCLC)
    Lin, H. M.
    Pan, X.
    Hou, P.
    Huang, H.
    Baumann, P.
    Jahanzeb, M.
    VALUE IN HEALTH, 2019, 22 : S115 - S115
  • [7] Real-World Experience of Nivolumab in Non-small Cell Lung Cancer in Korea
    Lim, Sun Min
    Kim, Sang-We
    Cho, Byoung Chul
    Kang, Jin Hyung
    Ahn, Myung-Ju
    Kim, Dong-Wan
    Kim, Young-Chul
    Lee, Jin Soo
    Lee, Jong-Seok
    Lee, Sung Yong
    Park, Keon Uk
    An, Ho Jung
    Cho, Eun Kyung
    Jang, Tae Won
    Kim, Bong-Seog
    Kim, Joo-Hang
    Lee, Sung Sook
    Na, Im-Il
    Yoo, Seung Soo
    Lee, Ki Hyeong
    CANCER RESEARCH AND TREATMENT, 2020, 52 (04): : 1112 - 1119
  • [8] LUMINATE 102: A real-world study on biomarker testing rates among patients with non-small cell lung cancer (NSCLC) across lines of therapy
    Aggarwal, C.
    Xu, Q.
    Ng, S.
    Kamalakar, R.
    Crawford, S. A.
    Beruti, S.
    Myftiu, A.
    Beasley, M. B.
    ANNALS OF ONCOLOGY, 2023, 34
  • [9] Real-World Biomarker Testing and Treatment Patterns for Locally Advanced and Metastatic Non-Small Cell Lung Cancer in Canada
    Laforty, C.
    Tong, M.
    Sharma, A.
    Kim, Y.
    Devost, N.
    Qadeer, R.
    Navani, V.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S656 - S657
  • [10] REAL-WORLD BIOMARKER TESTING RATES AMONG PATIENTS WITH WITH ADVANCED NON-SMALL CELL LUNG CANCER IN THE UNITED STATES
    Vieira, M. C.
    Kelton, J. M.
    Lamarre, N.
    Abraham, A.
    Duncan, K.
    Krulewicz, S.
    VALUE IN HEALTH, 2022, 25 (07) : S437 - S437
12345